Handelsavisen
prelaunch
Companies ›Healthcare ›NHZHY.PK
NH
NHZHY.PK — OTC Medical Equipment, Supplies & Distribution

New Horizon Health Ltd

$0,00
Open in Charts → Attach watcher ⌖
— —
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
-9,5 %
ROE
-3,8 %
Net margin
-10,5 %
Debt / equity
0,12
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

New Horizon Health Ltd provides medical equipment, supplies, and distribution services within the healthcare sector, generating revenue primarily through the sale and distribution of medical products and services.

Business. New Horizon Health Ltd (NHZHY.PK) operates in the Medical Equipment, Supplies & Distribution industry within the broader Healthcare Services & Equipment sector. The company primarily engages in the sale of medical products and equipment. Specific details regarding its operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the business is described at the industry level without further geographic or segmental breakdown.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
-3,8 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning NHZHY.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to NHZHY.PK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    New Horizon Health Ltd (NHZHY.PK) operates in the Medical Equipment, Supplies & Distribution industry within the broader Healthcare Services & Equipment sector. The company primarily engages in the sale of medical products and equipment. Specific details regarding its operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the business is described at the industry level without further geographic or segmental breakdown.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    New Horizon Health Ltd exhibits a capital structure with a debt-to-equity ratio of 0.12, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 8.8, suggesting strong short-term liquidity. However, the company's operating cash flow is negative at -412,538,000 CNY, and free cash flow is also negative at -107,825,000 CNY, indicating challenges in generating positive cash from operations.

    Profitability metrics show that the company is currently unprofitable, with a net loss of 80,313,000 CNY and an operating loss of 72,297,000 CNY. Return on equity is -3.79%, and return on assets is -3.12%, both significantly below the industry median for medical equipment and supplies distribution. Gross profit of 646,170,000 CNY represents a healthy margin, but this is insufficient to offset operating and net losses.

    The company's revenue is not segmented by geographic region or product line in the available data, making it difficult to assess geographic or segment concentration risks. However, the company's total revenue of 764,960,000 CNY is derived from its core operations in the medical equipment and supplies distribution sector.

    Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a decline in revenue and profitability, with no clear indication of improvement in the next fiscal year. The company's capital expenditure of -53,838,000 CNY suggests ongoing investment in infrastructure, but the negative operating and free cash flows indicate that these investments are not yet generating positive returns.

    Risk factors include a medium liquidity risk due to negative operating and free cash flows, and a key flag indicating that net cash is negative after subtracting total debt. The company's dilution risk is assessed as low, with no immediate pressure for share issuance. However, the company's unprofitable status and negative cash flows suggest potential for future dilution if capital needs increase.

    Recent events include the latest actual EPS of -0.19 CNY and actual revenue of 764,960,000 CNY, both reported in the most recent financial filings. These figures highlight the company's current financial challenges and the need for strategic improvements to achieve profitability and positive cash flow.

    Key takeaways
    • New Horizon Health Ltd is currently unprofitable with a net loss of 80,313,000 CNY and an operating loss of 72,297,000 CNY.
    • The company's liquidity position is strong with a current ratio of 8.8, but it faces challenges in generating positive operating and free cash flows.
    • The company's debt-to-equity ratio of 0.12 indicates a relatively low reliance on debt financing.
    • The company's return on equity and return on assets are significantly below the industry median, indicating poor profitability.
    • The company's growth trajectory is uncertain, with no clear indication of improvement in the next fiscal year.
    • **margin_outlook_rationale**: The company's gross margin is healthy, but the operating and net losses indicate that cost management and operational efficiency need improvement to enhance profitability.
    • **rd_outlook_rationale**: There is no specific information provided about the company's research and development activities or their impact on future growth.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $0,00
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    $2.12B
    Net cashⓘ
    -$245.0M
    Current ratioⓘ
    8.8
    Debt / equityⓘ
    0.1
    ROAⓘ
    -3.1%
    ROEⓘ
    -3.8%
    Cash conversionⓘ
    514.0%
    CapEx / revenueⓘ
    -7.0%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-9,4 %Below median
    Net Margin-10,5 %Below median
    ROE-3,8 %Below median
    Capex / Rev-7,0 %Below median
    D/E0,12Above median
    Cash Conv5,14Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • New Horizon Health Ltd Market data — financials · 2026-05-28
    • New Horizon Health Ltd Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    NHZHY.PKCanonical
    OTC · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage